Diabetic foot infections: Questions for an infectious disease consultant
Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious dise...
Saved in:
Published in | Seminars in vascular surgery Vol. 38; no. 1; pp. 85 - 93 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.03.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines. |
---|---|
AbstractList | Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines. ABSTRACTDiabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines. Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines.Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines. |
Author | Nauriyal, Varidhi Byers, Karin |
Author_xml | – sequence: 1 givenname: Varidhi surname: Nauriyal fullname: Nauriyal, Varidhi email: nauriyalv@upmc.edu organization: Divisions of Infectious Disease and Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, University of Pittsburgh Medical Center, 3601 Fifth Avenue, Falk Medical Building, 7th Floor, Pittsburgh, PA 15213 – sequence: 2 givenname: Karin surname: Byers fullname: Byers, Karin organization: Division of Infectious Disease, Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40086926$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV9rFTEQxYNU7G31K8j65suuk9xkk_gglOufCgUR9Tlks7OS695szewW-u3NemsRQehTAufM4cxvzthJmhIy9oJDw0FtX-0bwsONp0BL_t4IEKoB3gDYR2zDlTK1VNycsA0Yq2ptW33Kzoj2AKJthX7CTiWAaa1oN-zybfQdzjFUwzTNVUwDhjlOiV5Xnxek398i5cqne3Ghqo-EnrAKRV7G2af5KXs8-JHw2d17zr69f_d1d1lfffrwcXdxVYdtK-faKxCik9ANvUVlWgmlh9eog--96oyRerDYAnrQRgbspTK-68LQWWtAi-05e3nMvc7Tz7WhO0QKOI4-YWnmtlxrabjitlif31mX7oC9u87x4POt-7N9MdijIeSJKONwb-HgVtJu7_4i7VbSDrgrpMvs7jiLZdmbiNlRiJhK45gLJddP8UEpb_5JCWNMMfjxB94i7aclp0LTcUfCgfuyXnQ9qFAAwDmUgIv_BzywxC8mrbj0 |
Cites_doi | 10.1111/dme.13537 10.1053/j.jfas.2011.08.005 10.1002/dmrr.3250 10.1086/380449 10.1016/0002-9343(87)90894-1 10.1093/cid/ciw445 10.1111/j.1464-5491.2010.03150.x 10.1007/s00125-008-0940-0 10.1093/cid/cis346 10.1053/j.jfas.2006.04.002 10.3310/hta23610 10.4084/MJHID.2022.055 10.1093/clind/24.4.643 10.1093/ofid/ofy331 10.1080/07853890.2016.1231932 10.1056/NEJMoa1710926 10.1086/498112 10.2337/dc13-1526 10.1086/511036 10.1001/jama.2023.10578 10.1186/s13063-021-05472-6 10.2337/dc14-1514 10.1016/j.jcot.2020.12.014 10.1016/j.ejvs.2019.03.040 10.1002/dmrr.2425 10.1093/ofid/ofaa393 10.1007/s00125-006-0491-1 10.2337/dci22-0043 10.1093/cid/ciaa1758 10.1007/s10096-019-03547-6 10.1001/jamanetworkopen.2022.11321 10.1002/dmrr.3686 10.1001/jamanetworkopen.2019.16003 |
ContentType | Journal Article |
Copyright | 2025 Elsevier Inc. Elsevier Inc. Copyright © 2025 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2025 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2025 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1053/j.semvascsurg.2025.01.009 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1558-4518 |
EndPage | 93 |
ExternalDocumentID | 40086926 10_1053_j_semvascsurg_2025_01_009 S0895796725000110 1_s2_0_S0895796725000110 |
Genre | Journal Article Review |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OK- OW- OZT P-8 P-9 P2P PC. Q38 ROL RPZ SDF SDG SEL SES SPCBC SSH SSZ T5K UNMZH Z5R ZGI ~G- AFCTW AGRNS AACTN AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c364t-a5022b40bfd9e58640692a7e7cada5b8847f9e60ea0784ced458abbcfb9980723 |
IEDL.DBID | .~1 |
ISSN | 0895-7967 1558-4518 |
IngestDate | Thu Aug 07 14:14:53 EDT 2025 Thu May 15 23:18:57 EDT 2025 Tue Jul 01 05:07:56 EDT 2025 Sat May 03 15:55:14 EDT 2025 Fri May 16 03:43:10 EDT 2025 Tue Aug 26 18:14:54 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Osteomyelitis Infectious Diabetes Antibiotics Guidelines |
Language | English |
License | Copyright © 2025 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c364t-a5022b40bfd9e58640692a7e7cada5b8847f9e60ea0784ced458abbcfb9980723 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
PMID | 40086926 |
PQID | 3177481519 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_3177481519 pubmed_primary_40086926 crossref_primary_10_1053_j_semvascsurg_2025_01_009 elsevier_sciencedirect_doi_10_1053_j_semvascsurg_2025_01_009 elsevier_clinicalkeyesjournals_1_s2_0_S0895796725000110 elsevier_clinicalkey_doi_10_1053_j_semvascsurg_2025_01_009 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-03-01 |
PublicationDateYYYYMMDD | 2025-03-01 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Seminars in vascular surgery |
PublicationTitleAlternate | Semin Vasc Surg |
PublicationYear | 2025 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Zhang, Lu, Jing (bib0002) 2017; 49 Schechter, Ali, Risk (bib0019) 2020; 7 Lipsky, Berendt, Cornia (bib0026) 2012; 54 Sr, MS, Armstrong (bib0007) 2014; 59 Senneville, Lipsky, van Asten (bib0015) 2020; 36 Senneville, Melliez, Beltrand (bib0016) 2006; 42 Ndosi, Wright-Hughes, Brown (bib0004) 2018; 35 Lam, van Asten, Nguyen (bib0010) 2016; 63 Meyr, Singh, Zhang (bib0020) 2011; 50 Lázaro-Martínez, García-Madrid, García-Álvarez (bib0032) 2020; 16 Aragón-Sánchez, Lipsky, JL (bib0013) 2011; 28 Wilson, Bessesen, Doros (bib0028) 2019; 2 van Reijen, Ponchant, Ubbink (bib0008) 2019; 58 FDA approves Dalvance to treat skin infections [press release]. US Food and Drug Administration. May 23, 2014. Armstrong, Tan, Boulton (bib0009) 2023; 330 Prompers, Huijberts, Apelqvist (bib0033) 2007; 50 Rappo, Puttagunta, Shevchenko (bib0037) 2019; 6 Senneville, Albalawi, van Asten (bib0005) 2023; 79 Accessed 10/10/2024. McDermott, Fang, Boulton (bib0003) 2023; 46 Gramberg, Lagrand, Sabelis (bib0021) 2021; 22 Prompers, Schaper, Apelqvist (bib0034) 2008; 51 Lavery, Armstrong, Murdoch (bib0006) 2007; 44 Lipsky, Itani, Norden (bib0029) 2004; 38 Spellberg, Aggrey, Brennan (bib0022) 2022; 5 Fitridge, Chuter, Mills (bib0035) 2024; 40 Llewellyn, Jones-Diette, Kraft (bib0011) 2019; 23 Leone, Bianco, D'Ambra (bib0012) 2022; 14 Faglia, Clerici, Caminiti (bib0031) 2006; 45 Tone, Nguyen, Devemy (bib0024) 2015; 38 Gariani, Pham, Kressmann (bib0025) 2020; 73 Accessed 2/16/2024. Malone, Bowling, Gannass (bib0017) 2013; 29 Bamberger, Daus, Gerding (bib0030) 1987; 83 Lázaro-Martínez, Aragon-Sanchez, Garcia-Morales (bib0023) 2014; 37 Li, Rombach, Zambellas (bib0027) 2019; 380 National diabetes statistics report. Centers for Disease Control and Prevention. Lipsky, Baker, Landon (bib0014) 1997; 24 Couturier, Chabaud, Desbiez (bib0018) 2019; 38 Zhang (10.1053/j.semvascsurg.2025.01.009_bib0002) 2017; 49 Lázaro-Martínez (10.1053/j.semvascsurg.2025.01.009_bib0023) 2014; 37 Lavery (10.1053/j.semvascsurg.2025.01.009_bib0006) 2007; 44 Prompers (10.1053/j.semvascsurg.2025.01.009_bib0034) 2008; 51 van Reijen (10.1053/j.semvascsurg.2025.01.009_bib0008) 2019; 58 Lipsky (10.1053/j.semvascsurg.2025.01.009_bib0029) 2004; 38 Llewellyn (10.1053/j.semvascsurg.2025.01.009_bib0011) 2019; 23 Gariani (10.1053/j.semvascsurg.2025.01.009_bib0025) 2020; 73 Spellberg (10.1053/j.semvascsurg.2025.01.009_bib0022) 2022; 5 Sr (10.1053/j.semvascsurg.2025.01.009_bib0007) 2014; 59 Armstrong (10.1053/j.semvascsurg.2025.01.009_bib0009) 2023; 330 Schechter (10.1053/j.semvascsurg.2025.01.009_bib0019) 2020; 7 Lázaro-Martínez (10.1053/j.semvascsurg.2025.01.009_bib0032) 2020; 16 Meyr (10.1053/j.semvascsurg.2025.01.009_bib0020) 2011; 50 Gramberg (10.1053/j.semvascsurg.2025.01.009_bib0021) 2021; 22 Rappo (10.1053/j.semvascsurg.2025.01.009_bib0037) 2019; 6 Prompers (10.1053/j.semvascsurg.2025.01.009_bib0033) 2007; 50 Couturier (10.1053/j.semvascsurg.2025.01.009_bib0018) 2019; 38 10.1053/j.semvascsurg.2025.01.009_bib0001 Senneville (10.1053/j.semvascsurg.2025.01.009_bib0005) 2023; 79 Ndosi (10.1053/j.semvascsurg.2025.01.009_bib0004) 2018; 35 Senneville (10.1053/j.semvascsurg.2025.01.009_bib0016) 2006; 42 Wilson (10.1053/j.semvascsurg.2025.01.009_bib0028) 2019; 2 10.1053/j.semvascsurg.2025.01.009_bib0036 Lipsky (10.1053/j.semvascsurg.2025.01.009_bib0026) 2012; 54 Lipsky (10.1053/j.semvascsurg.2025.01.009_bib0014) 1997; 24 Bamberger (10.1053/j.semvascsurg.2025.01.009_bib0030) 1987; 83 Lam (10.1053/j.semvascsurg.2025.01.009_bib0010) 2016; 63 Malone (10.1053/j.semvascsurg.2025.01.009_bib0017) 2013; 29 Li (10.1053/j.semvascsurg.2025.01.009_bib0027) 2019; 380 Fitridge (10.1053/j.semvascsurg.2025.01.009_bib0035) 2024; 40 Leone (10.1053/j.semvascsurg.2025.01.009_bib0012) 2022; 14 Faglia (10.1053/j.semvascsurg.2025.01.009_bib0031) 2006; 45 Aragón-Sánchez (10.1053/j.semvascsurg.2025.01.009_bib0013) 2011; 28 McDermott (10.1053/j.semvascsurg.2025.01.009_bib0003) 2023; 46 Senneville (10.1053/j.semvascsurg.2025.01.009_bib0015) 2020; 36 Tone (10.1053/j.semvascsurg.2025.01.009_bib0024) 2015; 38 |
References_xml | – volume: 2 year: 2019 ident: bib0028 article-title: Adjunctive rifampin therapy for diabetic foot osteomyelitis in the Veterans Health Administration publication-title: JAMA Netw Open – volume: 51 start-page: 747 year: 2008 end-page: 755 ident: bib0034 article-title: Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study publication-title: Diabetologia – volume: 6 start-page: ofy331 year: 2019 ident: bib0037 article-title: Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety publication-title: Open Forum Infect Dis – volume: 42 start-page: 57 year: 2006 end-page: 62 ident: bib0016 article-title: Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures publication-title: Clin Infect Dis – volume: 23 start-page: 1 year: 2019 end-page: 128 ident: bib0011 article-title: Imaging tests for the detection of osteomyelitis: a systematic review publication-title: Health Technol Assess – volume: 14 year: 2022 ident: bib0012 article-title: The role of serial radiographs in diagnosing diabetic foot bone osteomyelitis publication-title: Mediterr J Hematol Infect Dis – reference: , Accessed 2/16/2024. – volume: 63 start-page: 944 year: 2016 end-page: 948 ident: bib0010 article-title: Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review publication-title: Clin Infect Dis – volume: 29 start-page: 546 year: 2013 end-page: 550 ident: bib0017 article-title: Deep wound cultures correlate well with bone biopsy culture in diabetic foot osteomyelitis publication-title: Diabetes Metab Res Rev – volume: 28 start-page: 191 year: 2011 end-page: 194 ident: bib0013 article-title: Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients? publication-title: Diabet Med – volume: 50 start-page: 663 year: 2011 end-page: 667 ident: bib0020 article-title: Statistical reliability of bone biopsy for the diagnosis of diabetic foot osteomyelitis publication-title: J Foot Ankle Surg – reference: , Accessed 10/10/2024. – reference: National diabetes statistics report. Centers for Disease Control and Prevention. – volume: 49 start-page: 106 year: 2017 end-page: 116 ident: bib0002 article-title: Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis publication-title: Ann Med – volume: 73 start-page: e1539 year: 2020 end-page: e1545 ident: bib0025 article-title: Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, non-inferiority pilot trial publication-title: Clin Infect Dis – volume: 54 start-page: e132 year: 2012 end-page: e173 ident: bib0026 article-title: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections publication-title: Clin Infect Dis – volume: 380 start-page: 425 year: 2019 end-page: 436 ident: bib0027 article-title: Oral versus intravenous antibiotics for bone and joint infection publication-title: N Engl J Med – volume: 50 start-page: 18 year: 2007 end-page: 25 ident: bib0033 article-title: High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study publication-title: Diabetologia – volume: 36 start-page: e3250 year: 2020 ident: bib0015 article-title: Diagnosing diabetic foot osteomyelitis publication-title: Diabetes Metab Res Rev – volume: 40 start-page: e3686 year: 2024 ident: bib0035 article-title: The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer publication-title: Diabetes Metab Res Rev – volume: 5 year: 2022 ident: bib0022 article-title: Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a WikiGuidelines Group Consensus Statement publication-title: JAMA Netw Open – volume: 58 start-page: 362 year: 2019 end-page: 371 ident: bib0008 article-title: The prognostic value of the WIfI classification in patients with chronic limb threatening ischaemia: a systematic review and meta-analysis publication-title: Eur J Vasc Endovasc Surg – volume: 38 start-page: 302 year: 2015 end-page: 307 ident: bib0024 article-title: Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study publication-title: Diabetes Care – volume: 7 start-page: ofaa393 year: 2020 ident: bib0019 article-title: Percutaneous bone biopsy for diabetic foot osteomyelitis: a systematic review and meta-analysis publication-title: Open Forum Infect Dis – volume: 22 start-page: 517 year: 2021 ident: bib0021 article-title: Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial publication-title: Trials – reference: FDA approves Dalvance to treat skin infections [press release]. US Food and Drug Administration. May 23, 2014. – volume: 59 year: 2014 ident: bib0007 article-title: The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI) publication-title: J Vasc Surg – volume: 24 start-page: 643 year: 1997 end-page: 648 ident: bib0014 article-title: Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens publication-title: Clin Infect Dis – volume: 83 start-page: 653 year: 1987 end-page: 660 ident: bib0030 article-title: Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy publication-title: Am J Med – volume: 46 start-page: 209 year: 2023 end-page: 221 ident: bib0003 article-title: Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers publication-title: Diabetes Care – volume: 330 start-page: 62 year: 2023 end-page: 75 ident: bib0009 article-title: Diabetic foot ulcers: a review publication-title: JAMA – volume: 38 start-page: 1287 year: 2019 end-page: 1291 ident: bib0018 article-title: Comparison of microbiological results obtained from per-wound bone biopsies versus transcutaneous bone biopsies in diabetic foot osteomyelitis: a prospective cohort study publication-title: Eur J Clin Microbiol Infect Dis – volume: 37 start-page: 789 year: 2014 end-page: 795 ident: bib0023 article-title: Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial publication-title: Diabetes Care – volume: 79 start-page: 286 year: 2023 ident: bib0005 article-title: IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) publication-title: Clin Infect Dis – volume: 44 start-page: 562 year: 2007 end-page: 565 ident: bib0006 article-title: Validation of the Infectious Diseases Society of America's diabetic foot infection classification system publication-title: Clin Infect Dis – volume: 38 start-page: 17 year: 2004 end-page: 24 ident: bib0029 article-title: Linezolid diabetic foot infections study group, treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate publication-title: Clin Infect Dis – volume: 45 start-page: 220 year: 2006 end-page: 226 ident: bib0031 article-title: The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes publication-title: J Foot Ankle Surg – volume: 35 start-page: 78 year: 2018 end-page: 88 ident: bib0004 article-title: Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study publication-title: Diabet Med – volume: 16 start-page: 86 year: 2020 end-page: 98 ident: bib0032 article-title: Conservative surgery for chronic diabetic foot osteomyelitis: procedures and recommendations publication-title: J Clin Orthop Trauma – volume: 35 start-page: 78 year: 2018 ident: 10.1053/j.semvascsurg.2025.01.009_bib0004 article-title: Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study publication-title: Diabet Med doi: 10.1111/dme.13537 – volume: 50 start-page: 663 year: 2011 ident: 10.1053/j.semvascsurg.2025.01.009_bib0020 article-title: Statistical reliability of bone biopsy for the diagnosis of diabetic foot osteomyelitis publication-title: J Foot Ankle Surg doi: 10.1053/j.jfas.2011.08.005 – volume: 36 start-page: e3250 issue: suppl 1 year: 2020 ident: 10.1053/j.semvascsurg.2025.01.009_bib0015 article-title: Diagnosing diabetic foot osteomyelitis publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.3250 – volume: 38 start-page: 17 year: 2004 ident: 10.1053/j.semvascsurg.2025.01.009_bib0029 article-title: Linezolid diabetic foot infections study group, treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate publication-title: Clin Infect Dis doi: 10.1086/380449 – volume: 83 start-page: 653 year: 1987 ident: 10.1053/j.semvascsurg.2025.01.009_bib0030 article-title: Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy publication-title: Am J Med doi: 10.1016/0002-9343(87)90894-1 – volume: 63 start-page: 944 year: 2016 ident: 10.1053/j.semvascsurg.2025.01.009_bib0010 article-title: Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review publication-title: Clin Infect Dis doi: 10.1093/cid/ciw445 – volume: 28 start-page: 191 year: 2011 ident: 10.1053/j.semvascsurg.2025.01.009_bib0013 article-title: Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients? publication-title: Diabet Med doi: 10.1111/j.1464-5491.2010.03150.x – volume: 51 start-page: 747 year: 2008 ident: 10.1053/j.semvascsurg.2025.01.009_bib0034 article-title: Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study publication-title: Diabetologia doi: 10.1007/s00125-008-0940-0 – volume: 54 start-page: e132 year: 2012 ident: 10.1053/j.semvascsurg.2025.01.009_bib0026 article-title: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections publication-title: Clin Infect Dis doi: 10.1093/cid/cis346 – volume: 45 start-page: 220 year: 2006 ident: 10.1053/j.semvascsurg.2025.01.009_bib0031 article-title: The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes publication-title: J Foot Ankle Surg doi: 10.1053/j.jfas.2006.04.002 – volume: 23 start-page: 1 year: 2019 ident: 10.1053/j.semvascsurg.2025.01.009_bib0011 article-title: Imaging tests for the detection of osteomyelitis: a systematic review publication-title: Health Technol Assess doi: 10.3310/hta23610 – volume: 14 year: 2022 ident: 10.1053/j.semvascsurg.2025.01.009_bib0012 article-title: The role of serial radiographs in diagnosing diabetic foot bone osteomyelitis publication-title: Mediterr J Hematol Infect Dis doi: 10.4084/MJHID.2022.055 – volume: 24 start-page: 643 year: 1997 ident: 10.1053/j.semvascsurg.2025.01.009_bib0014 article-title: Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens publication-title: Clin Infect Dis doi: 10.1093/clind/24.4.643 – volume: 79 start-page: 286 year: 2023 ident: 10.1053/j.semvascsurg.2025.01.009_bib0005 article-title: IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) publication-title: Clin Infect Dis – volume: 6 start-page: ofy331 year: 2019 ident: 10.1053/j.semvascsurg.2025.01.009_bib0037 article-title: Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofy331 – volume: 49 start-page: 106 year: 2017 ident: 10.1053/j.semvascsurg.2025.01.009_bib0002 article-title: Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis publication-title: Ann Med doi: 10.1080/07853890.2016.1231932 – volume: 380 start-page: 425 year: 2019 ident: 10.1053/j.semvascsurg.2025.01.009_bib0027 article-title: Oral versus intravenous antibiotics for bone and joint infection publication-title: N Engl J Med doi: 10.1056/NEJMoa1710926 – volume: 42 start-page: 57 year: 2006 ident: 10.1053/j.semvascsurg.2025.01.009_bib0016 article-title: Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures publication-title: Clin Infect Dis doi: 10.1086/498112 – volume: 37 start-page: 789 year: 2014 ident: 10.1053/j.semvascsurg.2025.01.009_bib0023 article-title: Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial publication-title: Diabetes Care doi: 10.2337/dc13-1526 – volume: 44 start-page: 562 year: 2007 ident: 10.1053/j.semvascsurg.2025.01.009_bib0006 article-title: Validation of the Infectious Diseases Society of America's diabetic foot infection classification system publication-title: Clin Infect Dis doi: 10.1086/511036 – ident: 10.1053/j.semvascsurg.2025.01.009_bib0001 – volume: 330 start-page: 62 year: 2023 ident: 10.1053/j.semvascsurg.2025.01.009_bib0009 article-title: Diabetic foot ulcers: a review publication-title: JAMA doi: 10.1001/jama.2023.10578 – volume: 22 start-page: 517 year: 2021 ident: 10.1053/j.semvascsurg.2025.01.009_bib0021 article-title: Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial publication-title: Trials doi: 10.1186/s13063-021-05472-6 – ident: 10.1053/j.semvascsurg.2025.01.009_bib0036 – volume: 38 start-page: 302 year: 2015 ident: 10.1053/j.semvascsurg.2025.01.009_bib0024 article-title: Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study publication-title: Diabetes Care doi: 10.2337/dc14-1514 – volume: 16 start-page: 86 year: 2020 ident: 10.1053/j.semvascsurg.2025.01.009_bib0032 article-title: Conservative surgery for chronic diabetic foot osteomyelitis: procedures and recommendations publication-title: J Clin Orthop Trauma doi: 10.1016/j.jcot.2020.12.014 – volume: 58 start-page: 362 year: 2019 ident: 10.1053/j.semvascsurg.2025.01.009_bib0008 article-title: The prognostic value of the WIfI classification in patients with chronic limb threatening ischaemia: a systematic review and meta-analysis publication-title: Eur J Vasc Endovasc Surg doi: 10.1016/j.ejvs.2019.03.040 – volume: 59 year: 2014 ident: 10.1053/j.semvascsurg.2025.01.009_bib0007 article-title: The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI) publication-title: J Vasc Surg – volume: 29 start-page: 546 year: 2013 ident: 10.1053/j.semvascsurg.2025.01.009_bib0017 article-title: Deep wound cultures correlate well with bone biopsy culture in diabetic foot osteomyelitis publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.2425 – volume: 7 start-page: ofaa393 year: 2020 ident: 10.1053/j.semvascsurg.2025.01.009_bib0019 article-title: Percutaneous bone biopsy for diabetic foot osteomyelitis: a systematic review and meta-analysis publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofaa393 – volume: 50 start-page: 18 year: 2007 ident: 10.1053/j.semvascsurg.2025.01.009_bib0033 article-title: High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study publication-title: Diabetologia doi: 10.1007/s00125-006-0491-1 – volume: 46 start-page: 209 year: 2023 ident: 10.1053/j.semvascsurg.2025.01.009_bib0003 article-title: Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers publication-title: Diabetes Care doi: 10.2337/dci22-0043 – volume: 73 start-page: e1539 year: 2020 ident: 10.1053/j.semvascsurg.2025.01.009_bib0025 article-title: Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, non-inferiority pilot trial publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa1758 – volume: 38 start-page: 1287 year: 2019 ident: 10.1053/j.semvascsurg.2025.01.009_bib0018 article-title: Comparison of microbiological results obtained from per-wound bone biopsies versus transcutaneous bone biopsies in diabetic foot osteomyelitis: a prospective cohort study publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-019-03547-6 – volume: 5 year: 2022 ident: 10.1053/j.semvascsurg.2025.01.009_bib0022 article-title: Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a WikiGuidelines Group Consensus Statement publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.11321 – volume: 40 start-page: e3686 year: 2024 ident: 10.1053/j.semvascsurg.2025.01.009_bib0035 article-title: The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.3686 – volume: 2 year: 2019 ident: 10.1053/j.semvascsurg.2025.01.009_bib0028 article-title: Adjunctive rifampin therapy for diabetic foot osteomyelitis in the Veterans Health Administration publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2019.16003 |
SSID | ssj0026627 |
Score | 2.3895845 |
SecondaryResourceType | review_article |
Snippet | Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot... ABSTRACTDiabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 85 |
SubjectTerms | Amputation, Surgical Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Antibiotics Clinical Decision-Making Consultants Diabetes Diabetic Foot - diagnosis Diabetic Foot - microbiology Diabetic Foot - therapy Guidelines Humans Infectious Limb Salvage Osteomyelitis Patient Care Team Referral and Consultation Risk Factors Surgery Treatment Outcome |
Title | Diabetic foot infections: Questions for an infectious disease consultant |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0895796725000110 https://www.clinicalkey.es/playcontent/1-s2.0-S0895796725000110 https://dx.doi.org/10.1053/j.semvascsurg.2025.01.009 https://www.ncbi.nlm.nih.gov/pubmed/40086926 https://www.proquest.com/docview/3177481519 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ZS8MwGA9jgvgiitc8Rge-1nVp0mP4MoZjXkPUwd5C0iYy0G6s3at_u9_XYyhOGPjUIwkpv3z5jn5HCLmEDcZDzzCbRZ3AZlyGtmQRxj-ZGMS7G0cSE4UfR95wzO4mfFIj_SoXBsMqS95f8PScW5dv2iWa7fl02n5xAnQxeT7luWKDdjtjPlL51ecqzINigfNckwyxNKPnb5NWcbqt28as7g8M-EyXizcwFWlRwRNjE9fLqL900FwWDfbIbqlEWr3iO_dJTScHZFgEt0wjy8xmmVVFWSVp18r_auItNC0smawal6lVemisCHMx3_FM4UMyHty89od2eU6CHbkey2zJQRAr5igTh5oHHiazUulrP5Kx5CoAAWRC7Tlagj7AAFjGA6lUZBTYWo5P3SNST2aJPiGWkWAOBhyMMm0Y8GTluDDAgFYF_WisGoRWyIh5UQ5D5G5s7oIZ8Q1OgXAKpyMAzgbpVhiKKt8TOJQApr3JYH_dYJ2Wey0VHZFS4Yhf9NAg16uRP0hq04lb1XIL2HLoR5GJhoURoHL5WOOmA32OCzpYgcHQRgypd_q_yc_IDj4VwW7npJ4tlvoCtJ9MNXPybpKtXv_54Qmvt_fD0ReTWwhn |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bSxwxFD6IQvWlWOplW7UR9HHc2Uwyl0UfpFXW64sK-xaTmUQW2tllZ5fii3_KP-g5c1latCCUfRsmCRm-JOcy5zsnAHt4wGQSOuGJtBN7QurE0yIl_pPLUL0HWaopUfjqOuzdifO-7C_Ac5MLQ7TKWvZXMr2U1vWbdo1mezQYtG_8mEJMYcRladj4NbPywj7-Rr-tODr7gYu8z_npye33nldfLeClQSgmnpaou4zwjcsSK-OQ8j-5jmyU6kxLE6PMdokNfatRhQr8FiFjbUzqDLonfkTVDlDuLwkUF3RtwsHTjFfCqaJ6abomVAsyjD7AbnWdbtCmNPJfxDAtpuMH9E15VTKUyJBvK8V_Gb2l8jtdhY-11cqOK2A-wYLNP0OvYtMMUuaGwwlraF150WXlb1R6xKYx0_mscVqwOiTEUkr-_EmXGK_B3VzQW4fFfJjbTWBOo_8ZS_QCrROoBIwf4ACHZhz245lpAW-QUaOq_oYq4-YyQL_lDzgVwan8jkI4W9BtMFRNgimKRIVa4j2Do7cG26I-3IXqqIIrX73agC04nI38aw-_d-LdZrkVnnEK3Ojc4sIotPEiKqrTwT4b1T6YgSHIKU14-OX_Jv8Gy73bq0t1eXZ98RVWqKVi2m3B4mQ8tdtoek3MTrnVGdzP-2y9AI94Qxg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diabetic+foot+infections%3A+Questions+for+an+infectious+disease+consultant&rft.jtitle=Seminars+in+vascular+surgery&rft.au=Nauriyal%2C+Varidhi&rft.au=Byers%2C+Karin&rft.date=2025-03-01&rft.issn=0895-7967&rft.volume=38&rft.issue=1&rft.spage=85&rft.epage=93&rft_id=info:doi/10.1053%2Fj.semvascsurg.2025.01.009&rft.externalDBID=n%2Fa&rft.externalDocID=10_1053_j_semvascsurg_2025_01_009 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08957967%2FS0895796725X00028%2Fcov150h.gif |